Search bioRxiv⌕ Search

Biology subjects

Onzi, G. R.

Publications and source records attributed to Onzi, G. R..

2 recordsLinked to original sources

SCOUT: Single-cell outlier analysis in cancer

Outliers are often ignored or even removed from data analysis. In cancer, however, single outlier cells can be of major importance, since they have uncommon characteristics that may confer capacity to invade, metastasize, or resist to therapy. Here we present the Single-Cell OUTlier analysis (SCOUT), a resource for single-cell data analysis focusing on outlier cells, and the SCOUT Selector (SCOUTS), an application to systematically apply SCOUT on a dataset over a wide range of biological markers. Using publicly available datasets of cancer samples obtained from mass cytometry and single-cell RNA-seq platforms, outlier cells for the expression of proteins or RNAs were identified and compared to their non-outlier counterparts among different samples. Our results show that analyzing single-cell data using SCOUT can uncover key information not easily observed in the analysis of the whole population.

bioinformatics↗

Global immune fingerprinting in glioblastoma reveals immune-suppression signatures associated with prognosis

Abstract/SummaryGlioblastoma (GBM) remains uniformly lethal, and, despite a large accumulation of immune cells in the microenvironment, there is limited anti-tumor immune response, even with newly developed immune checkpoint therapies. To overcome these challenges and enhance the efficacy of immunotherapies, a comprehensive understanding of the immune system in GBM and changes during disease progression is required. Here, we integrated multi-parameter flow cytometry and mass cytometry time of flight (CyTOF) analysis of patient blood to determine changes in the immune system among tumor types and over disease progression. Utilizing multi-parameter flow cytometry analysis in a cohort of over 250 patients with brain tumors ranging from benign to malignant primary and metastatic, we found that GBM patients had a significant elevation in myeloid-derived suppressor cells (MDSCs) in blood, but not immunosuppressive T regulatory cells. We validated these findings in GBM patient tissue and found that increased numbers of MDSCs in recurrent GBM portended poor prognosis. CyTOF analysis of peripheral blood from a cohort of newly diagnosed GBM patients revealed that reduction in MDSC frequency over time is accompanied by a concomitant increase in dendritic cells and natural killer cells. This reduced MDSC profile was present in GBM patients with extended survival and was similar to that of low-grade glioma (LGG) patients. Our findings provide a rationale for developing strategies to target MDSCs, which are elevated in GBM patients and predict poor prognosis, either by directly targeting or by shifting the immune profile to induce differentiation toward the immune profile of LGGs.

cancer biology↗